Arbutus Biopharma Corp.

(NASDAQ:ABUS)
formerly known as Tekmira Pharmaceuticals Corp.

Collapse Summary General Information
 Location Burnaby, B.C.
 Region British Columbia
 Country Canada
 Business Category Cancer, Infectious, Neurology
 Year Founded 2005
 Website http://arbutusbio.com
 Lead Product Status Market (drug)
Get a free BioCentury trial today
 Archive Items are loading loading
 Financial Information
 
 Earnings Summary
 Stocks Annual Chart
Week of 11/17/2017 - 887,434 Week of 11/10/2017 - 729,754 Week of 11/03/2017 - 1,826,545 Week of 10/27/2017 - 1,498,269 Week of 10/20/2017 - 1,441,798 Week of 10/13/2017 - 1,859,169 Week of 10/06/2017 - 4,484,528 Week of 09/29/2017 - 2,255,858 Week of 09/22/2017 - 7,060,420 Week of 09/15/2017 - 1,009,208 Week of 09/08/2017 - 480,513 Week of 09/01/2017 - 609,479 Week of 08/25/2017 - 415,165 Week of 08/18/2017 - 262,247 Week of 08/11/2017 - 299,349 Week of 08/04/2017 - 294,181 Week of 07/28/2017 - 383,196 Week of 07/21/2017 - 325,067 Week of 07/14/2017 - 259,570 Week of 07/07/2017 - 316,353 Week of 06/30/2017 - 452,081 Week of 06/23/2017 - 499,408 Week of 06/16/2017 - 663,992 Week of 06/09/2017 - 1,435,119 Week of 06/02/2017 - 488,062 Week of 05/26/2017 - 426,868 Week of 05/19/2017 - 2,691,239 Week of 05/12/2017 - 1,006,455 Week of 05/05/2017 - 438,866 Week of 04/28/2017 - 796,456 Week of 04/21/2017 - 845,330 Week of 04/14/2017 - 860,919 Week of 04/07/2017 - 1,040,037 Week of 03/31/2017 - 992,044 Week of 03/24/2017 - 1,445,865 Week of 03/17/2017 - 3,744,908 Week of 03/10/2017 - 339,350 Week of 03/03/2017 - 356,711 Week of 02/24/2017 - 178,904 Week of 02/17/2017 - 404,184 Week of 02/10/2017 - 645,940 Week of 02/03/2017 - 464,472 Week of 01/27/2017 - 450,976 Week of 01/20/2017 - 803,963 Week of 01/13/2017 - 1,368,824 Week of 01/06/2017 - 2,284,665 Week of 12/30/2016 - 3,660,257 Week of 12/23/2016 - 1,789,160 Week of 12/16/2016 - 2,459,619 Week of 12/09/2016 - 1,653,290 Week of 12/02/2016 - 3,311,800 Week of 11/25/2016 - 794,395 Week of 11/18/2016 - 351,966
 Pipeline Information
 
 Deals Information